# CalciMedica, Inc. (CALC)

> Source: Nexqual · https://nexqual.com/CALC · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, CalciMedica, Inc. (CALC), nexqual.com/CALC" · informational, not investment advice.

**Price:** USD 1.08 (+0.94% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.08 · day 1.05–1.15 · 52w 1.03–36 · market cap null · NCM

## Key facts
- Analysts: Buy (mean 2.25 on a 1–5 scale) (4 analysts), mean target USD 50 (range 30–75).
- Total return with dividends: 1Y -93.3% vs S&P 500 +18.1%; 5Y -95.7% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 2.25 on a 1–5 scale), 4 analysts; mean target USD 50 (low 30, high 75).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-20 | Guggenheim | Initiated | Buy | $9 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2023-06-12) |
|---|---|---|
| Total return | -93.3% | -95.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -93.4% | -61.0% |
| Volatility (annualized) | 186.1% | 139.5% |
| Max drawdown | -96.8% (Jan 2026→Oct 2026) | -96.8% (Dec 2025→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/CALC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt